
Fablums Medizone Private Limited
About Fablums Medizone Private Limited
Data last updated:
Fablums Medizone Private Limited is a private limited company based in Thrissur, Kerala, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 13 September 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Ernakulam, under CIN U74999KL2017PTC050392. The company has 1 GST registration on record, which is no longer active.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors Thekkekkara Anthony Davis (Managing Director) and Vinod Davis.
Its last annual general meeting (AGM) was held on 30 September 2020, and its latest financial statements are for the year ended 31 March 2020. The registered office is at 12/343 E/F Christ College Road Irinjalakuda, Thrissur, Kerala, India – 680125.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Fablums Medizone Private Limited's registered office is in Thrissur, Kerala.
- Registered Address12/343 E/F Christ College Road Irinjalakuda, Thrissur, Kerala, India – 680125
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Fablums Medizone Private Limited
FY 2020 filings availableFinancial Statement Summary
| Metrics | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | |||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | |||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | |||
| Net Profit Margin | |||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Fablums Medizone Private Limited, buy the company report.
Board of directors of Fablums Medizone Private Limited
Fablums Medizone has 2 current directors and 11 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Thekkekkara Anthony Davis Also directs: Ellil Industries Private Limited | Managing Director | 12 Jan 2022 | 4 Years 9 Months | Current |
| Vinod Davis | Director | 12 Jan 2022 | 4 Years 9 Months | Current |
Legal cases
No court or tribunal cases involving Fablums Medizone Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Fablums Medizone Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Fablums Medizone has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of Fablums Medizone Private Limited, buy the company report.
Recent activity
Fablums Medizone Private Limited has 13 board changes on record since 2017: 2 appointments and 11 cessations. The latest: Karengal Kunhibappu Shamsudheen ceased to be Managing Director on 20 Jan 2022.
4 earlier events are in the company report.
Frequently asked questions
Fablums Medizone is an active private limited company based in Thrissur, Kerala, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 13 September 2017 (9+ years old) and is registered under CIN U74999KL2017PTC050392.
Fablums Medizone has 2 current directors:
- Thekkekkara Anthony Davis - Managing Director
- Vinod Davis - Director
The latest financial statements of Fablums Medizone on record with the MCA are for the year ended 31 March 2020. Its last annual general meeting was held on 30 September 2020. Year-wise statements from FY 2018 are in the company report.
No. Fablums Medizone has 1 GST registration on record and it is cancelled or inactive.
The CIN (Corporate Identification Number) of Fablums Medizone is U74999KL2017PTC050392. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Fablums Medizone was incorporated on 13 September 2017, making it 9+ years old. It is registered with the Registrar of Companies, Ernakulam.
Karengal Kunhibappu Shamsudheen ceased to be Managing Director on 20 Jan 2022. Karengal Shamsudheen Shabira ceased to be Director on 20 Jan 2022. Thekkekkara Anthony Davis was appointed as Managing Director on 12 Jan 2022. Fablums Medizone has 13 board changes on record in total.
The registered office of Fablums Medizone is at 12343 EF Christ College Road Irinjalakuda, Thrissur, Kerala, India – 680125.
Fablums Medizone operates in the pharma industry, in the drug formulation and development segment.
The compliance status of Fablums Medizone is compliant as of 26 August 2026. The company is actively filing with the Registrar of Companies.

